Trial Profile
Clinical Trials Insight: 700045758
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 May 2010
Price :
$35
*
At a glance
- Drugs Gataparsen (Primary)
- Indications Cancer
- Focus Pharmacodynamics
- 20 May 2010 Status changed from not stated to completed.
- 10 Jun 2009 New trial record.
- 01 Jun 2009 Data presented at the American Society of Clinical Oncology (ASCO) 2009 annual meeting, according to an Isis media release.